TD Cowen analyst Tyler Van Buren maintained a Buy rating on Regeneron (REGN – Research Report) today and set a price target of $1,030.00. The ...

TD Cowen analyst Joseph Thome maintained a Hold rating on PTC Therapeutics (PTCT – Research Report) today and set a price target of $50.00. The ...

Large law firms have begun 2025 with a jolt in Boston, as Am Law 50 firms such as Sidley Austin, Jones Day and Holland & ...

The consumer advocacy group has uncovered discounts of up to 9% off MSRP on these 10 car and SUV models—but you have to act fast.

Our research examines how global health challenges manifest themselves as international affairs problems. Our global health programme focuses on analysing and informing efforts to prevent global ...

In a new video update, crypto strategist Benjamin Cowen tells his 857,000 YouTube subscribers that if bad US economic data comes out, ADA may collapse to much lower levels. However, he says if the ...

These developments are expected to enable the company to tap into higher growth rates and capitalize on the expanding opportunities in the healthcare sector. Cardinal Health's stock rating upgrade and ...

On Tuesday, TD Cowen analysts revised their outlook on Acadia Healthcare (NASDAQ:ACHC), reducing the price target from $70.00 to $66.00 while maintaining a Buy rating on the company's stock. Trading ...

TD Cowen lowered the firm’s price target on Acadia Healthcare (ACHC) to $66 from $70 and keeps a Buy rating on the shares. The firm lowered forward annual EBITDA estimates for by 4% largely to ...